Peter Bisgaard
SlowingNamed in filings at Pivotal bioVenture PartnersOn the current fund
- Board seats filed
- 12
Named in filings at Pivotal bioVenture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Addition Therapeutics | Biotech & pharma | December 2025 | None on file |
| OncXerna Therapeutics | Biotech & pharma | February 2022 | None on file |
| MapLight Therapeutics | Biotech & pharma | February 2019 | None on file |
| Eargo | Medical devices | October 2017 | Maveron, NEA |
| Bolt Biotherapeutics | Biotech & pharma | September 2016 | Capra CLO Founders, Sofinnova Venture Partners, Vivo Innovation |
| Outpost Medicine | Biotech & pharma | March 2016 | Passage BIO Inc, TCG Crossover, Tcgx Asia Life Sciences, Vivo Innovation |
| Ra Pharmaceuticals | Biotech & pharma | July 2015 | NEA |
| THESAN PHARMACEUTICALS | Biotech & pharma | February 2014 | SV Life Sciences, Virtuoso-mccarran |
| HTG MOLECULAR DIAGNOSTICS | Biotech & pharma | February 2014 | None on file |
| Ceterix Orthopaedics | Medical devices | December 2012 | NEA, Versant Venture Capital, Westlake Biopartners |
| Light Sciences Oncology | Biotech & pharma | January 2012 | None on file |
| Altheos | Biotech & pharma | July 2011 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Peter Bisgaard on the board, based on 12 filed seats with a verified or cited source.